We advised the Egyptian Company for Medical Investments (ECMI) on its EGP 1.4 billion partnership with Japan’s JMS Singapore Pte. Ltd. (JMS) to establish a medical manufacturing facility in Ain Sokhna’s Suez Canal Economic Zone (SCZone), dedicated to the production of blood bags and pouches.

The partnership will enable the facility to meet 100% of local demand, reduce reliance on imports, and export to markets across the Middle East and North Africa—supporting Egypt’s broader strategy to localise key industries and enhance healthcare resilience.

The transaction was led by Mohamed Abdelgawad, Partner and Head of General Corporate, Commercial, and Regulatory, along with Fadila Abdelaziz, Counsel.

The signing ceremony, witnessed by H.E. Prime Minister Dr. Mostafa Madbouly, underscores the government’s commitment to fostering local industry and attracting foreign direct investment in the healthcare sector. ADSERO Partners Mohamed AbdelGawad and Mohamed Fathy were also in attendance.

Congratulations to Osama Abdel Baset, Chairman of ECMI, on this significant achievement.

We were pleased to collaborate with Ahmed Sami, Chairman and CEO of Interpharm Egypt; Masafumi Sato, Executive Director of JMS Japan; and the legal teams from Khodeir & Partners—Amr Noureldin, Partner; Ahmed Owais L.L.B, DPL., L.L.M, MCIArb, Counsel; and Associates Abdelrahman Abdelghany and Ali Ismail, advisors to JMS. We also extend our thanks to Hazim A. Rizkana, Managing Partner, and Youssef Rizkana, Senior Associate at Rizkana & Partners, legal advisors to Interpharm.

For more information, read Ahram Online coverage here.